SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-001428
Filing Date
2020-01-21
Accepted
2020-01-21 11:53:35
Documents
41
Period of Report
2019-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1119_bespokeextracts.htm 10-Q 351374
2 CERTIFICATION f10q1119ex31-1_bespoke.htm EX-31.1 10288
3 CERTIFICATION f10q1119ex32-1_bespoke.htm EX-32.1 6390
  Complete submission text file 0001213900-20-001428.txt   2255438

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bspk-20191130.xml EX-101.INS 260055
5 XBRL SCHEMA FILE bspk-20191130.xsd EX-101.SCH 33514
6 XBRL CALCULATION FILE bspk-20191130_cal.xml EX-101.CAL 31918
7 XBRL DEFINITION FILE bspk-20191130_def.xml EX-101.DEF 155742
8 XBRL LABEL FILE bspk-20191130_lab.xml EX-101.LAB 241908
9 XBRL PRESENTATION FILE bspk-20191130_pre.xml EX-101.PRE 201319
Mailing Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160
Business Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 20535691
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences